Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
· 10/29/2026, 3:18:06 PM· 2 min read
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Read original story →Related stories
business
LANXESS, BPCL join hands to develop next-gen lubricant solutions
business
Deepavali sales expected to gain momentum in Coimbatore next week
business
Dr. Shetty moves Bombay High Court seeking directions against Bank of Baroda in NMC Healthcare case
business